Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has seen an upward revision in normalized Funds From Operations (NFFO) estimates due to stronger-than-expected performance in the second quarter of 2025, alongside a positive outlook communicated by management. The updated projections indicate a 2025 normalized FFO estimate of $4.80 per share, aligning with management’s guidance and exceeding the consensus estimate, contributing to an optimistic financial forecast. Additionally, the 2026 FFO estimate has been raised to $5.03 per share, surpassing market expectations, which further supports a favorable assessment of the company's financial outlook.

Bears say

National Health Investors Inc. faces a negative outlook primarily due to expected lower earnings growth over the next few years, driven by the challenges associated with operator transitions and issues. Concerns over potential lower-than-anticipated rent resets from NHC and risks related to deferred rent collections heighten the company's vulnerability to market fluctuations. Additionally, the possibility of operator challenges, exacerbated by factors such as pandemic-related impacts, further underscores the financial risks facing the REIT.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.